nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—BCHE—breast cancer	0.624	1	CbGaD
Succinylcholine—CHRM3—muscle of abdomen—breast cancer	0.0114	0.182	CbGeAlD
Succinylcholine—CHRNE—pituitary gland—breast cancer	0.00824	0.132	CbGeAlD
Succinylcholine—CHRNG—nipple—breast cancer	0.00753	0.12	CbGeAlD
Succinylcholine—Carbachol—PLA2G4A—breast cancer	0.00528	0.519	CrCbGaD
Succinylcholine—CHRNG—adipose tissue—breast cancer	0.0041	0.0655	CbGeAlD
Succinylcholine—CHRNG—bone marrow—breast cancer	0.00356	0.0568	CbGeAlD
Succinylcholine—Decamethonium—ACHE—breast cancer	0.00308	0.303	CrCbGaD
Succinylcholine—CHRNA1—endocrine gland—breast cancer	0.00211	0.0337	CbGeAlD
Succinylcholine—CHRNB1—adipose tissue—breast cancer	0.0021	0.0335	CbGeAlD
Succinylcholine—CHRNB1—adrenal gland—breast cancer	0.00188	0.03	CbGeAlD
Succinylcholine—CHRNA10—lymph node—breast cancer	0.00187	0.0299	CbGeAlD
Succinylcholine—Decamethonium—BCHE—breast cancer	0.00181	0.178	CrCbGaD
Succinylcholine—CHRNB1—female gonad—breast cancer	0.00175	0.028	CbGeAlD
Succinylcholine—BCHE—nipple—breast cancer	0.00164	0.0262	CbGeAlD
Succinylcholine—CHRNB1—lymph node—breast cancer	0.00113	0.018	CbGeAlD
Succinylcholine—CHRM1—female reproductive system—breast cancer	0.00112	0.018	CbGeAlD
Succinylcholine—CHRM3—adipose tissue—breast cancer	0.00109	0.0175	CbGeAlD
Succinylcholine—BCHE—skin of body—breast cancer	0.00105	0.0168	CbGeAlD
Succinylcholine—CHRM2—endocrine gland—breast cancer	0.00104	0.0167	CbGeAlD
Succinylcholine—CHRM3—female reproductive system—breast cancer	0.00101	0.0161	CbGeAlD
Succinylcholine—BCHE—endometrium—breast cancer	0.000991	0.0158	CbGeAlD
Succinylcholine—CHRM1—endocrine gland—breast cancer	0.000951	0.0152	CbGeAlD
Succinylcholine—CHRM3—female gonad—breast cancer	0.000915	0.0146	CbGeAlD
Succinylcholine—BCHE—uterus—breast cancer	0.000913	0.0146	CbGeAlD
Succinylcholine—BCHE—pituitary gland—breast cancer	0.000897	0.0143	CbGeAlD
Succinylcholine—BCHE—adipose tissue—breast cancer	0.000893	0.0143	CbGeAlD
Succinylcholine—CHRM3—endocrine gland—breast cancer	0.000851	0.0136	CbGeAlD
Succinylcholine—BCHE—female reproductive system—breast cancer	0.000821	0.0131	CbGeAlD
Succinylcholine—BCHE—adrenal gland—breast cancer	0.000801	0.0128	CbGeAlD
Succinylcholine—BCHE—bone marrow—breast cancer	0.000775	0.0124	CbGeAlD
Succinylcholine—Musculoskeletal discomfort—Raloxifene—breast cancer	0.00076	0.0038	CcSEcCtD
Succinylcholine—Renal failure—Thiotepa—breast cancer	0.000757	0.00378	CcSEcCtD
Succinylcholine—Arrhythmia—Tamoxifen—breast cancer	0.000756	0.00378	CcSEcCtD
Succinylcholine—Arrhythmia—Melphalan—breast cancer	0.000741	0.0037	CcSEcCtD
Succinylcholine—Body temperature increased—Ixabepilone—breast cancer	0.000738	0.00369	CcSEcCtD
Succinylcholine—Pulmonary oedema—Docetaxel—breast cancer	0.000732	0.00366	CcSEcCtD
Succinylcholine—Hypersensitivity—Exemestane—breast cancer	0.000729	0.00364	CcSEcCtD
Succinylcholine—Arrhythmia—Goserelin—breast cancer	0.000722	0.00361	CcSEcCtD
Succinylcholine—Rash—Fulvestrant—breast cancer	0.000718	0.00359	CcSEcCtD
Succinylcholine—Dermatitis—Fulvestrant—breast cancer	0.000717	0.00358	CcSEcCtD
Succinylcholine—Bronchospasm—Gemcitabine—breast cancer	0.000715	0.00357	CcSEcCtD
Succinylcholine—Rash—Toremifene—breast cancer	0.000709	0.00354	CcSEcCtD
Succinylcholine—Dermatitis—Toremifene—breast cancer	0.000708	0.00354	CcSEcCtD
Succinylcholine—Apnoea—Methotrexate—breast cancer	0.000699	0.00349	CcSEcCtD
Succinylcholine—Urticaria—Letrozole—breast cancer	0.000698	0.00349	CcSEcCtD
Succinylcholine—Urticaria—Anastrozole—breast cancer	0.000698	0.00349	CcSEcCtD
Succinylcholine—Body temperature increased—Anastrozole—breast cancer	0.000695	0.00347	CcSEcCtD
Succinylcholine—Body temperature increased—Letrozole—breast cancer	0.000695	0.00347	CcSEcCtD
Succinylcholine—BCHE—endocrine gland—breast cancer	0.000695	0.0111	CbGeAlD
Succinylcholine—Hypersensitivity—Ixabepilone—breast cancer	0.000688	0.00344	CcSEcCtD
Succinylcholine—Flushing—Vinorelbine—breast cancer	0.000672	0.00336	CcSEcCtD
Succinylcholine—Cardiac arrest—Paclitaxel—breast cancer	0.00067	0.00335	CcSEcCtD
Succinylcholine—Urticaria—Idarubicin—breast cancer	0.000663	0.00331	CcSEcCtD
Succinylcholine—Body temperature increased—Raloxifene—breast cancer	0.000659	0.00329	CcSEcCtD
Succinylcholine—Body temperature increased—Idarubicin—breast cancer	0.000659	0.00329	CcSEcCtD
Succinylcholine—Hypertension—Vinblastine—breast cancer	0.000655	0.00327	CcSEcCtD
Succinylcholine—Renal failure—Irinotecan—breast cancer	0.000654	0.00327	CcSEcCtD
Succinylcholine—Renal failure—Mitoxantrone—breast cancer	0.000654	0.00327	CcSEcCtD
Succinylcholine—Hypersensitivity—Anastrozole—breast cancer	0.000648	0.00324	CcSEcCtD
Succinylcholine—Arrhythmia—Vinorelbine—breast cancer	0.000647	0.00323	CcSEcCtD
Succinylcholine—Renal failure—Gemcitabine—breast cancer	0.000637	0.00318	CcSEcCtD
Succinylcholine—Hypertension—Tamoxifen—breast cancer	0.000636	0.00318	CcSEcCtD
Succinylcholine—Myalgia—Tamoxifen—breast cancer	0.000627	0.00313	CcSEcCtD
Succinylcholine—Renal failure acute—Capecitabine—breast cancer	0.000626	0.00313	CcSEcCtD
Succinylcholine—Rash—Exemestane—breast cancer	0.000624	0.00312	CcSEcCtD
Succinylcholine—Dermatitis—Exemestane—breast cancer	0.000623	0.00311	CcSEcCtD
Succinylcholine—Arrhythmia—Thiotepa—breast cancer	0.000618	0.00309	CcSEcCtD
Succinylcholine—Hypersensitivity—Idarubicin—breast cancer	0.000615	0.00307	CcSEcCtD
Succinylcholine—Myalgia—Melphalan—breast cancer	0.000614	0.00307	CcSEcCtD
Succinylcholine—Bradycardia—Mitoxantrone—breast cancer	0.000608	0.00304	CcSEcCtD
Succinylcholine—Bradycardia—Irinotecan—breast cancer	0.000608	0.00304	CcSEcCtD
Succinylcholine—Hypertension—Goserelin—breast cancer	0.000608	0.00304	CcSEcCtD
Succinylcholine—Respiratory failure—Methotrexate—breast cancer	0.000603	0.00301	CcSEcCtD
Succinylcholine—Myalgia—Goserelin—breast cancer	0.000599	0.00299	CcSEcCtD
Succinylcholine—Anaphylactic shock—Melphalan—breast cancer	0.000589	0.00294	CcSEcCtD
Succinylcholine—Rash—Ixabepilone—breast cancer	0.000589	0.00294	CcSEcCtD
Succinylcholine—Dermatitis—Ixabepilone—breast cancer	0.000588	0.00294	CcSEcCtD
Succinylcholine—Tachycardia—Melphalan—breast cancer	0.000575	0.00287	CcSEcCtD
Succinylcholine—Anaphylactic shock—Goserelin—breast cancer	0.000574	0.00287	CcSEcCtD
Succinylcholine—Shock—Goserelin—breast cancer	0.000565	0.00282	CcSEcCtD
Succinylcholine—Tachycardia—Goserelin—breast cancer	0.000561	0.0028	CcSEcCtD
Succinylcholine—Flushing—Irinotecan—breast cancer	0.000554	0.00277	CcSEcCtD
Succinylcholine—Rash—Letrozole—breast cancer	0.000554	0.00277	CcSEcCtD
Succinylcholine—Rash—Anastrozole—breast cancer	0.000554	0.00277	CcSEcCtD
Succinylcholine—Dermatitis—Anastrozole—breast cancer	0.000554	0.00277	CcSEcCtD
Succinylcholine—Dermatitis—Letrozole—breast cancer	0.000554	0.00277	CcSEcCtD
Succinylcholine—Hypotension—Melphalan—breast cancer	0.00055	0.00275	CcSEcCtD
Succinylcholine—Cardiac arrest—Capecitabine—breast cancer	0.000549	0.00275	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Tamoxifen—breast cancer	0.000548	0.00274	CcSEcCtD
Succinylcholine—Hyperkalaemia—Epirubicin—breast cancer	0.000545	0.00272	CcSEcCtD
Succinylcholine—Hypertension—Vinorelbine—breast cancer	0.000544	0.00272	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Epirubicin—breast cancer	0.000539	0.00269	CcSEcCtD
Succinylcholine—Hypotension—Goserelin—breast cancer	0.000537	0.00268	CcSEcCtD
Succinylcholine—Urticaria—Chlorambucil—breast cancer	0.000537	0.00268	CcSEcCtD
Succinylcholine—Myalgia—Vinorelbine—breast cancer	0.000537	0.00268	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Melphalan—breast cancer	0.000537	0.00268	CcSEcCtD
Succinylcholine—Body temperature increased—Chlorambucil—breast cancer	0.000534	0.00267	CcSEcCtD
Succinylcholine—Arrhythmia—Mitoxantrone—breast cancer	0.000534	0.00267	CcSEcCtD
Succinylcholine—Arrhythmia—Irinotecan—breast cancer	0.000534	0.00267	CcSEcCtD
Succinylcholine—Renal failure—Paclitaxel—breast cancer	0.000533	0.00266	CcSEcCtD
Succinylcholine—Pulmonary oedema—Methotrexate—breast cancer	0.000527	0.00264	CcSEcCtD
Succinylcholine—Rash—Idarubicin—breast cancer	0.000526	0.00263	CcSEcCtD
Succinylcholine—Rash—Raloxifene—breast cancer	0.000526	0.00263	CcSEcCtD
Succinylcholine—Dermatitis—Idarubicin—breast cancer	0.000525	0.00263	CcSEcCtD
Succinylcholine—Dermatitis—Raloxifene—breast cancer	0.000525	0.00263	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Goserelin—breast cancer	0.000523	0.00261	CcSEcCtD
Succinylcholine—Hypertension—Thiotepa—breast cancer	0.00052	0.0026	CcSEcCtD
Succinylcholine—Arrhythmia—Gemcitabine—breast cancer	0.00052	0.0026	CcSEcCtD
Succinylcholine—Anaphylactic shock—Vinorelbine—breast cancer	0.000515	0.00257	CcSEcCtD
Succinylcholine—Myalgia—Thiotepa—breast cancer	0.000513	0.00256	CcSEcCtD
Succinylcholine—Arrhythmia—Fluorouracil—breast cancer	0.000511	0.00255	CcSEcCtD
Succinylcholine—Bronchospasm—Docetaxel—breast cancer	0.000507	0.00253	CcSEcCtD
Succinylcholine—Hyperkalaemia—Doxorubicin—breast cancer	0.000504	0.00252	CcSEcCtD
Succinylcholine—Tachycardia—Vinorelbine—breast cancer	0.000502	0.00251	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Doxorubicin—breast cancer	0.000498	0.00249	CcSEcCtD
Succinylcholine—Hypersensitivity—Chlorambucil—breast cancer	0.000498	0.00249	CcSEcCtD
Succinylcholine—Bradycardia—Paclitaxel—breast cancer	0.000496	0.00248	CcSEcCtD
Succinylcholine—Pulmonary oedema—Epirubicin—breast cancer	0.000494	0.00247	CcSEcCtD
Succinylcholine—Bronchospasm—Capecitabine—breast cancer	0.000491	0.00245	CcSEcCtD
Succinylcholine—Hypertonia—Epirubicin—breast cancer	0.000486	0.00243	CcSEcCtD
Succinylcholine—Hypotension—Vinorelbine—breast cancer	0.000481	0.0024	CcSEcCtD
Succinylcholine—BCHE—lymph node—breast cancer	0.00048	0.00767	CbGeAlD
Succinylcholine—Tachycardia—Thiotepa—breast cancer	0.00048	0.0024	CcSEcCtD
Succinylcholine—Urticaria—Tamoxifen—breast cancer	0.000478	0.00239	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Vinorelbine—breast cancer	0.000469	0.00234	CcSEcCtD
Succinylcholine—Urticaria—Melphalan—breast cancer	0.000468	0.00234	CcSEcCtD
Succinylcholine—Renal failure acute—Methotrexate—breast cancer	0.000466	0.00233	CcSEcCtD
Succinylcholine—Pulmonary oedema—Doxorubicin—breast cancer	0.000457	0.00228	CcSEcCtD
Succinylcholine—Urticaria—Goserelin—breast cancer	0.000456	0.00228	CcSEcCtD
Succinylcholine—Hypersensitivity—Vinblastine—breast cancer	0.000456	0.00228	CcSEcCtD
Succinylcholine—Body temperature increased—Goserelin—breast cancer	0.000454	0.00227	CcSEcCtD
Succinylcholine—Renal failure—Docetaxel—breast cancer	0.000452	0.00226	CcSEcCtD
Succinylcholine—Flushing—Paclitaxel—breast cancer	0.000452	0.00226	CcSEcCtD
Succinylcholine—Hypertonia—Doxorubicin—breast cancer	0.00045	0.00225	CcSEcCtD
Succinylcholine—Hypertension—Irinotecan—breast cancer	0.000449	0.00224	CcSEcCtD
Succinylcholine—Hypertension—Mitoxantrone—breast cancer	0.000449	0.00224	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Thiotepa—breast cancer	0.000448	0.00224	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Methotrexate—breast cancer	0.000444	0.00222	CcSEcCtD
Succinylcholine—Hypersensitivity—Tamoxifen—breast cancer	0.000443	0.00221	CcSEcCtD
Succinylcholine—Myalgia—Mitoxantrone—breast cancer	0.000443	0.00221	CcSEcCtD
Succinylcholine—Renal failure—Capecitabine—breast cancer	0.000438	0.00219	CcSEcCtD
Succinylcholine—Hypertension—Gemcitabine—breast cancer	0.000437	0.00218	CcSEcCtD
Succinylcholine—Renal failure acute—Epirubicin—breast cancer	0.000436	0.00218	CcSEcCtD
Succinylcholine—Arrhythmia—Paclitaxel—breast cancer	0.000435	0.00217	CcSEcCtD
Succinylcholine—Hypersensitivity—Melphalan—breast cancer	0.000434	0.00217	CcSEcCtD
Succinylcholine—Myalgia—Gemcitabine—breast cancer	0.000431	0.00215	CcSEcCtD
Succinylcholine—Anaphylactic shock—Irinotecan—breast cancer	0.000424	0.00212	CcSEcCtD
Succinylcholine—Anaphylactic shock—Mitoxantrone—breast cancer	0.000424	0.00212	CcSEcCtD
Succinylcholine—Myalgia—Fluorouracil—breast cancer	0.000424	0.00212	CcSEcCtD
Succinylcholine—Hypersensitivity—Goserelin—breast cancer	0.000423	0.00211	CcSEcCtD
Succinylcholine—Shock—Mitoxantrone—breast cancer	0.000417	0.00209	CcSEcCtD
Succinylcholine—Shock—Irinotecan—breast cancer	0.000417	0.00209	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Epirubicin—breast cancer	0.000416	0.00208	CcSEcCtD
Succinylcholine—Tachycardia—Mitoxantrone—breast cancer	0.000414	0.00207	CcSEcCtD
Succinylcholine—Anaphylactic shock—Gemcitabine—breast cancer	0.000413	0.00207	CcSEcCtD
Succinylcholine—Urticaria—Vinorelbine—breast cancer	0.000409	0.00204	CcSEcCtD
Succinylcholine—Bradycardia—Capecitabine—breast cancer	0.000407	0.00203	CcSEcCtD
Succinylcholine—Body temperature increased—Vinorelbine—breast cancer	0.000407	0.00203	CcSEcCtD
Succinylcholine—Anaphylactic shock—Fluorouracil—breast cancer	0.000406	0.00203	CcSEcCtD
Succinylcholine—Renal failure acute—Doxorubicin—breast cancer	0.000403	0.00202	CcSEcCtD
Succinylcholine—Tachycardia—Fluorouracil—breast cancer	0.000397	0.00198	CcSEcCtD
Succinylcholine—Hypotension—Irinotecan—breast cancer	0.000397	0.00198	CcSEcCtD
Succinylcholine—Hypotension—Mitoxantrone—breast cancer	0.000397	0.00198	CcSEcCtD
Succinylcholine—Urticaria—Thiotepa—breast cancer	0.00039	0.00195	CcSEcCtD
Succinylcholine—Body temperature increased—Thiotepa—breast cancer	0.000388	0.00194	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000387	0.00193	CcSEcCtD
Succinylcholine—Hypotension—Gemcitabine—breast cancer	0.000386	0.00193	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Doxorubicin—breast cancer	0.000385	0.00192	CcSEcCtD
Succinylcholine—Flushing—Docetaxel—breast cancer	0.000383	0.00191	CcSEcCtD
Succinylcholine—Cardiac arrest—Epirubicin—breast cancer	0.000383	0.00191	CcSEcCtD
Succinylcholine—Hypotension—Fluorouracil—breast cancer	0.00038	0.0019	CcSEcCtD
Succinylcholine—Rash—Tamoxifen—breast cancer	0.000379	0.00189	CcSEcCtD
Succinylcholine—Hypersensitivity—Vinorelbine—breast cancer	0.000379	0.00189	CcSEcCtD
Succinylcholine—Dermatitis—Tamoxifen—breast cancer	0.000379	0.00189	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000377	0.00188	CcSEcCtD
Succinylcholine—Rash—Melphalan—breast cancer	0.000371	0.00186	CcSEcCtD
Succinylcholine—Flushing—Capecitabine—breast cancer	0.000371	0.00185	CcSEcCtD
Succinylcholine—Dermatitis—Melphalan—breast cancer	0.000371	0.00185	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.00037	0.00185	CcSEcCtD
Succinylcholine—Arrhythmia—Docetaxel—breast cancer	0.000369	0.00184	CcSEcCtD
Succinylcholine—Hypertension—Paclitaxel—breast cancer	0.000366	0.00183	CcSEcCtD
Succinylcholine—Rash—Goserelin—breast cancer	0.000362	0.00181	CcSEcCtD
Succinylcholine—Hypersensitivity—Thiotepa—breast cancer	0.000362	0.00181	CcSEcCtD
Succinylcholine—Dermatitis—Goserelin—breast cancer	0.000362	0.00181	CcSEcCtD
Succinylcholine—Myalgia—Paclitaxel—breast cancer	0.000361	0.0018	CcSEcCtD
Succinylcholine—Arrhythmia—Capecitabine—breast cancer	0.000357	0.00178	CcSEcCtD
Succinylcholine—Cardiac arrest—Doxorubicin—breast cancer	0.000354	0.00177	CcSEcCtD
Succinylcholine—Anaphylactic shock—Paclitaxel—breast cancer	0.000346	0.00173	CcSEcCtD
Succinylcholine—Shock—Paclitaxel—breast cancer	0.00034	0.0017	CcSEcCtD
Succinylcholine—Tachycardia—Paclitaxel—breast cancer	0.000338	0.00169	CcSEcCtD
Succinylcholine—Urticaria—Mitoxantrone—breast cancer	0.000337	0.00168	CcSEcCtD
Succinylcholine—Body temperature increased—Mitoxantrone—breast cancer	0.000335	0.00168	CcSEcCtD
Succinylcholine—Body temperature increased—Irinotecan—breast cancer	0.000335	0.00168	CcSEcCtD
Succinylcholine—Body temperature increased—Gemcitabine—breast cancer	0.000327	0.00163	CcSEcCtD
Succinylcholine—Renal failure—Methotrexate—breast cancer	0.000326	0.00163	CcSEcCtD
Succinylcholine—Rash—Vinorelbine—breast cancer	0.000324	0.00162	CcSEcCtD
Succinylcholine—Dermatitis—Vinorelbine—breast cancer	0.000324	0.00162	CcSEcCtD
Succinylcholine—Hypotension—Paclitaxel—breast cancer	0.000323	0.00162	CcSEcCtD
Succinylcholine—Urticaria—Fluorouracil—breast cancer	0.000323	0.00161	CcSEcCtD
Succinylcholine—Body temperature increased—Fluorouracil—breast cancer	0.000321	0.00161	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000315	0.00158	CcSEcCtD
Succinylcholine—Hypersensitivity—Mitoxantrone—breast cancer	0.000313	0.00156	CcSEcCtD
Succinylcholine—Hypersensitivity—Irinotecan—breast cancer	0.000313	0.00156	CcSEcCtD
Succinylcholine—Hypertension—Docetaxel—breast cancer	0.00031	0.00155	CcSEcCtD
Succinylcholine—Rash—Thiotepa—breast cancer	0.00031	0.00155	CcSEcCtD
Succinylcholine—Dermatitis—Thiotepa—breast cancer	0.00031	0.00155	CcSEcCtD
Succinylcholine—Myalgia—Docetaxel—breast cancer	0.000306	0.00153	CcSEcCtD
Succinylcholine—Renal failure—Epirubicin—breast cancer	0.000305	0.00152	CcSEcCtD
Succinylcholine—Hypertension—Capecitabine—breast cancer	0.0003	0.0015	CcSEcCtD
Succinylcholine—Hypersensitivity—Fluorouracil—breast cancer	0.000299	0.0015	CcSEcCtD
Succinylcholine—Myalgia—Capecitabine—breast cancer	0.000296	0.00148	CcSEcCtD
Succinylcholine—Anaphylactic shock—Docetaxel—breast cancer	0.000293	0.00147	CcSEcCtD
Succinylcholine—Shock—Docetaxel—breast cancer	0.000289	0.00144	CcSEcCtD
Succinylcholine—Tachycardia—Docetaxel—breast cancer	0.000286	0.00143	CcSEcCtD
Succinylcholine—Bradycardia—Epirubicin—breast cancer	0.000284	0.00142	CcSEcCtD
Succinylcholine—Renal failure—Doxorubicin—breast cancer	0.000282	0.00141	CcSEcCtD
Succinylcholine—Shock—Capecitabine—breast cancer	0.000279	0.0014	CcSEcCtD
Succinylcholine—Tachycardia—Capecitabine—breast cancer	0.000277	0.00138	CcSEcCtD
Succinylcholine—Urticaria—Paclitaxel—breast cancer	0.000275	0.00137	CcSEcCtD
Succinylcholine—Hypotension—Docetaxel—breast cancer	0.000274	0.00137	CcSEcCtD
Succinylcholine—Body temperature increased—Paclitaxel—breast cancer	0.000274	0.00137	CcSEcCtD
Succinylcholine—Rash—Mitoxantrone—breast cancer	0.000268	0.00134	CcSEcCtD
Succinylcholine—Rash—Irinotecan—breast cancer	0.000268	0.00134	CcSEcCtD
Succinylcholine—Dermatitis—Mitoxantrone—breast cancer	0.000267	0.00134	CcSEcCtD
Succinylcholine—Dermatitis—Irinotecan—breast cancer	0.000267	0.00134	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000267	0.00134	CcSEcCtD
Succinylcholine—Hypotension—Capecitabine—breast cancer	0.000265	0.00133	CcSEcCtD
Succinylcholine—Bradycardia—Doxorubicin—breast cancer	0.000262	0.00131	CcSEcCtD
Succinylcholine—Rash—Gemcitabine—breast cancer	0.000261	0.0013	CcSEcCtD
Succinylcholine—Dermatitis—Gemcitabine—breast cancer	0.00026	0.0013	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000259	0.00129	CcSEcCtD
Succinylcholine—Flushing—Epirubicin—breast cancer	0.000258	0.00129	CcSEcCtD
Succinylcholine—Rash—Fluorouracil—breast cancer	0.000256	0.00128	CcSEcCtD
Succinylcholine—Dermatitis—Fluorouracil—breast cancer	0.000256	0.00128	CcSEcCtD
Succinylcholine—Hypersensitivity—Paclitaxel—breast cancer	0.000255	0.00127	CcSEcCtD
Succinylcholine—Arrhythmia—Epirubicin—breast cancer	0.000249	0.00124	CcSEcCtD
Succinylcholine—Flushing—Doxorubicin—breast cancer	0.000239	0.00119	CcSEcCtD
Succinylcholine—Body temperature increased—Docetaxel—breast cancer	0.000232	0.00116	CcSEcCtD
Succinylcholine—Arrhythmia—Doxorubicin—breast cancer	0.00023	0.00115	CcSEcCtD
Succinylcholine—Urticaria—Capecitabine—breast cancer	0.000226	0.00113	CcSEcCtD
Succinylcholine—Body temperature increased—Capecitabine—breast cancer	0.000225	0.00112	CcSEcCtD
Succinylcholine—Myalgia—Methotrexate—breast cancer	0.000221	0.0011	CcSEcCtD
Succinylcholine—Rash—Paclitaxel—breast cancer	0.000218	0.00109	CcSEcCtD
Succinylcholine—Dermatitis—Paclitaxel—breast cancer	0.000218	0.00109	CcSEcCtD
Succinylcholine—Hypersensitivity—Docetaxel—breast cancer	0.000216	0.00108	CcSEcCtD
Succinylcholine—Anaphylactic shock—Methotrexate—breast cancer	0.000211	0.00106	CcSEcCtD
Succinylcholine—Hypertension—Epirubicin—breast cancer	0.000209	0.00105	CcSEcCtD
Succinylcholine—Hypersensitivity—Capecitabine—breast cancer	0.000209	0.00105	CcSEcCtD
Succinylcholine—Myalgia—Epirubicin—breast cancer	0.000206	0.00103	CcSEcCtD
Succinylcholine—Anaphylactic shock—Epirubicin—breast cancer	0.000198	0.000989	CcSEcCtD
Succinylcholine—Hypotension—Methotrexate—breast cancer	0.000198	0.000987	CcSEcCtD
Succinylcholine—Shock—Epirubicin—breast cancer	0.000195	0.000973	CcSEcCtD
Succinylcholine—Hypertension—Doxorubicin—breast cancer	0.000194	0.000968	CcSEcCtD
Succinylcholine—Tachycardia—Epirubicin—breast cancer	0.000193	0.000965	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000193	0.000962	CcSEcCtD
Succinylcholine—Myalgia—Doxorubicin—breast cancer	0.000191	0.000954	CcSEcCtD
Succinylcholine—Rash—Docetaxel—breast cancer	0.000185	0.000924	CcSEcCtD
Succinylcholine—Hypotension—Epirubicin—breast cancer	0.000185	0.000924	CcSEcCtD
Succinylcholine—Dermatitis—Docetaxel—breast cancer	0.000185	0.000923	CcSEcCtD
Succinylcholine—Anaphylactic shock—Doxorubicin—breast cancer	0.000183	0.000915	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Epirubicin—breast cancer	0.00018	0.000901	CcSEcCtD
Succinylcholine—Shock—Doxorubicin—breast cancer	0.00018	0.0009	CcSEcCtD
Succinylcholine—Rash—Capecitabine—breast cancer	0.000179	0.000895	CcSEcCtD
Succinylcholine—Dermatitis—Capecitabine—breast cancer	0.000179	0.000894	CcSEcCtD
Succinylcholine—Tachycardia—Doxorubicin—breast cancer	0.000179	0.000893	CcSEcCtD
Succinylcholine—Hypotension—Doxorubicin—breast cancer	0.000171	0.000855	CcSEcCtD
Succinylcholine—Urticaria—Methotrexate—breast cancer	0.000168	0.000839	CcSEcCtD
Succinylcholine—Body temperature increased—Methotrexate—breast cancer	0.000167	0.000835	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000167	0.000833	CcSEcCtD
Succinylcholine—Urticaria—Epirubicin—breast cancer	0.000157	0.000785	CcSEcCtD
Succinylcholine—Body temperature increased—Epirubicin—breast cancer	0.000156	0.000781	CcSEcCtD
Succinylcholine—Hypersensitivity—Methotrexate—breast cancer	0.000156	0.000778	CcSEcCtD
Succinylcholine—Hypersensitivity—Epirubicin—breast cancer	0.000146	0.000728	CcSEcCtD
Succinylcholine—Urticaria—Doxorubicin—breast cancer	0.000145	0.000727	CcSEcCtD
Succinylcholine—Body temperature increased—Doxorubicin—breast cancer	0.000145	0.000723	CcSEcCtD
Succinylcholine—Hypersensitivity—Doxorubicin—breast cancer	0.000135	0.000674	CcSEcCtD
Succinylcholine—Rash—Methotrexate—breast cancer	0.000133	0.000666	CcSEcCtD
Succinylcholine—Dermatitis—Methotrexate—breast cancer	0.000133	0.000665	CcSEcCtD
Succinylcholine—Rash—Epirubicin—breast cancer	0.000125	0.000623	CcSEcCtD
Succinylcholine—Dermatitis—Epirubicin—breast cancer	0.000125	0.000623	CcSEcCtD
Succinylcholine—Rash—Doxorubicin—breast cancer	0.000115	0.000577	CcSEcCtD
Succinylcholine—Dermatitis—Doxorubicin—breast cancer	0.000115	0.000576	CcSEcCtD
Succinylcholine—CHRM1—Signaling Pathways—IGF1R—breast cancer	1.06e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1R—breast cancer	1.06e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CXCL8—breast cancer	1.06e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SMAD4—breast cancer	1.06e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CXCL8—breast cancer	1.05e-05	0.000102	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CD—breast cancer	1.05e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1R—breast cancer	1.05e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	1.04e-05	0.000101	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HES1—breast cancer	1.04e-05	0.000101	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HES1—breast cancer	1.04e-05	0.000101	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PLA2G4A—breast cancer	1.04e-05	0.000101	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NCOR1—breast cancer	1.04e-05	0.000101	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ALB—breast cancer	1.04e-05	0.000101	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NCOR1—breast cancer	1.03e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PLA2G4A—breast cancer	1.03e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HES1—breast cancer	1.03e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGF1—breast cancer	1.03e-05	9.96e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CSF2—breast cancer	1.03e-05	9.96e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NCOR1—breast cancer	1.02e-05	9.94e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	1.02e-05	9.94e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—RAF1—breast cancer	1.02e-05	9.94e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGF1—breast cancer	1.02e-05	9.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CSF2—breast cancer	1.02e-05	9.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—RAF1—breast cancer	1.02e-05	9.9e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NRG1—breast cancer	1.02e-05	9.89e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NRG1—breast cancer	1.02e-05	9.85e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGF1—breast cancer	1.01e-05	9.83e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CSF2—breast cancer	1.01e-05	9.83e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—H2AFX—breast cancer	1.01e-05	9.82e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—IL2—breast cancer	1.01e-05	9.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—RAF1—breast cancer	1.01e-05	9.81e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CAV1—breast cancer	1.01e-05	9.79e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—H2AFX—breast cancer	1.01e-05	9.78e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—IL2—breast cancer	1.01e-05	9.78e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NRG1—breast cancer	1.01e-05	9.76e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—E2F1—breast cancer	1e-05	9.75e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—E2F1—breast cancer	1e-05	9.72e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	9.99e-06	9.7e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—H2AFX—breast cancer	9.98e-06	9.69e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—IL2—breast cancer	9.98e-06	9.68e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	9.96e-06	9.67e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—NOS3—breast cancer	9.92e-06	9.62e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—E2F1—breast cancer	9.91e-06	9.62e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	9.87e-06	9.58e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SPP1—breast cancer	9.65e-06	9.36e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SPP1—breast cancer	9.62e-06	9.33e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CXCL8—breast cancer	9.6e-06	9.32e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CXCL8—breast cancer	9.57e-06	9.29e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ERBB3—breast cancer	9.54e-06	9.26e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGFR2—breast cancer	9.53e-06	9.25e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SPP1—breast cancer	9.52e-06	9.24e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ERBB3—breast cancer	9.51e-06	9.23e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGFR2—breast cancer	9.5e-06	9.22e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CXCL8—breast cancer	9.48e-06	9.2e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ERBB3—breast cancer	9.42e-06	9.14e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGFR2—breast cancer	9.4e-06	9.13e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CG—breast cancer	9.19e-06	8.92e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL2—breast cancer	9.18e-06	8.91e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CB—breast cancer	9.15e-06	8.88e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL2—breast cancer	9.15e-06	8.88e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TERT—breast cancer	9.15e-06	8.88e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TERT—breast cancer	9.12e-06	8.85e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTGS2—breast cancer	9.07e-06	8.8e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL2—breast cancer	9.06e-06	8.79e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TERT—breast cancer	9.03e-06	8.76e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGFR1—breast cancer	8.88e-06	8.62e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGFR1—breast cancer	8.85e-06	8.59e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGFR1—breast cancer	8.77e-06	8.51e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HIF1A—breast cancer	8.75e-06	8.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HIF1A—breast cancer	8.72e-06	8.46e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HIF1A—breast cancer	8.63e-06	8.38e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LEP—breast cancer	8.54e-06	8.29e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LEP—breast cancer	8.51e-06	8.26e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CAV1—breast cancer	8.46e-06	8.21e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CAV1—breast cancer	8.43e-06	8.18e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LEP—breast cancer	8.43e-06	8.18e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KDR—breast cancer	8.36e-06	8.12e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CAV1—breast cancer	8.35e-06	8.11e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KDR—breast cancer	8.34e-06	8.09e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KDR—breast cancer	8.26e-06	8.01e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ESR1—breast cancer	8.15e-06	7.91e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ESR1—breast cancer	8.13e-06	7.89e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CD—breast cancer	8.08e-06	7.84e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FN1—breast cancer	8.05e-06	7.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ESR1—breast cancer	8.05e-06	7.81e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FN1—breast cancer	8.03e-06	7.79e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ALB—breast cancer	7.97e-06	7.74e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NFKBIA—breast cancer	7.96e-06	7.72e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FN1—breast cancer	7.95e-06	7.71e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NFKBIA—breast cancer	7.93e-06	7.7e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTEN—breast cancer	7.91e-06	7.68e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NOTCH1—breast cancer	7.88e-06	7.65e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NOTCH1—breast cancer	7.85e-06	7.62e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NFKBIA—breast cancer	7.85e-06	7.62e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NOTCH1—breast cancer	7.78e-06	7.55e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KIT—breast cancer	7.71e-06	7.48e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CG—breast cancer	7.71e-06	7.48e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APC—breast cancer	7.71e-06	7.48e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KIT—breast cancer	7.68e-06	7.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CG—breast cancer	7.68e-06	7.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APC—breast cancer	7.68e-06	7.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—NOS3—breast cancer	7.63e-06	7.4e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EGF—breast cancer	7.62e-06	7.39e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KIT—breast cancer	7.61e-06	7.38e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APC—breast cancer	7.61e-06	7.38e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CG—breast cancer	7.61e-06	7.38e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EGF—breast cancer	7.59e-06	7.37e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EGF—breast cancer	7.52e-06	7.3e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—MAPK3—breast cancer	7.38e-06	7.16e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—MAPK3—breast cancer	7.36e-06	7.14e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—MAPK3—breast cancer	7.28e-06	7.07e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—BRAF—breast cancer	7.24e-06	7.03e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—BRAF—breast cancer	7.22e-06	7.01e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—BRAF—breast cancer	7.15e-06	6.94e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF1—breast cancer	7.05e-06	6.85e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT2—breast cancer	7.05e-06	6.84e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CB—breast cancer	7.04e-06	6.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1—breast cancer	7.03e-06	6.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT2—breast cancer	7.03e-06	6.82e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—EGFR—breast cancer	7.02e-06	6.81e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—EGFR—breast cancer	7e-06	6.79e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTGS2—breast cancer	6.97e-06	6.77e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1—breast cancer	6.96e-06	6.76e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT2—breast cancer	6.96e-06	6.75e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—EGFR—breast cancer	6.93e-06	6.73e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CD—breast cancer	6.77e-06	6.57e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CD—breast cancer	6.75e-06	6.55e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	6.71e-06	6.51e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SERPINE1—breast cancer	6.7e-06	6.5e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	6.69e-06	6.49e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CD—breast cancer	6.69e-06	6.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SERPINE1—breast cancer	6.68e-06	6.48e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—KRAS—breast cancer	6.63e-06	6.44e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	6.62e-06	6.43e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SERPINE1—breast cancer	6.61e-06	6.42e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—KRAS—breast cancer	6.61e-06	6.42e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—KRAS—breast cancer	6.55e-06	6.35e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NOS3—breast cancer	6.4e-06	6.21e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NOS3—breast cancer	6.38e-06	6.19e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NOS3—breast cancer	6.31e-06	6.13e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	6.09e-06	5.91e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTEN—breast cancer	6.08e-06	5.9e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	6.07e-06	5.89e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MDM2—breast cancer	6.07e-06	5.89e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MDM2—breast cancer	6.05e-06	5.87e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—RAF1—breast cancer	6.05e-06	5.87e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—RAF1—breast cancer	6.03e-06	5.85e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—RELA—breast cancer	6.02e-06	5.84e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	6.01e-06	5.84e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—RELA—breast cancer	6e-06	5.83e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MDM2—breast cancer	5.99e-06	5.81e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ERBB2—breast cancer	5.98e-06	5.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—RAF1—breast cancer	5.97e-06	5.79e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ERBB2—breast cancer	5.96e-06	5.79e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—RELA—breast cancer	5.94e-06	5.77e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ERBB2—breast cancer	5.91e-06	5.73e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MTOR—breast cancer	5.9e-06	5.73e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CB—breast cancer	5.9e-06	5.73e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MTOR—breast cancer	5.89e-06	5.71e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CB—breast cancer	5.89e-06	5.71e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MTOR—breast cancer	5.83e-06	5.66e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	5.83e-06	5.66e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CXCL8—breast cancer	5.67e-06	5.51e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CXCL8—breast cancer	5.66e-06	5.49e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HRAS—breast cancer	5.64e-06	5.47e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HRAS—breast cancer	5.62e-06	5.45e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CXCL8—breast cancer	5.6e-06	5.44e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CA—breast cancer	5.58e-06	5.42e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HRAS—breast cancer	5.56e-06	5.4e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDKN1B—breast cancer	5.54e-06	5.38e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDKN1B—breast cancer	5.52e-06	5.36e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—breast cancer	5.48e-06	5.32e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	5.47e-06	5.31e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—breast cancer	5.46e-06	5.3e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CASP3—breast cancer	5.43e-06	5.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL2—breast cancer	5.42e-06	5.26e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CASP3—breast cancer	5.41e-06	5.25e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	5.41e-06	5.25e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL2—breast cancer	5.41e-06	5.25e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6—breast cancer	5.4e-06	5.24e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6—breast cancer	5.38e-06	5.22e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CASP3—breast cancer	5.36e-06	5.2e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL2—breast cancer	5.35e-06	5.2e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6—breast cancer	5.33e-06	5.17e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCND1—breast cancer	5.29e-06	5.13e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—JUN—breast cancer	5.27e-06	5.12e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCND1—breast cancer	5.27e-06	5.11e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—JUN—breast cancer	5.26e-06	5.1e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CTNNB1—breast cancer	5.23e-06	5.08e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCND1—breast cancer	5.22e-06	5.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CTNNB1—breast cancer	5.22e-06	5.06e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—JUN—breast cancer	5.21e-06	5.05e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	5.17e-06	5.02e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP9—breast cancer	5.13e-06	4.98e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP9—breast cancer	5.12e-06	4.97e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	5.11e-06	4.96e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTEN—breast cancer	5.1e-06	4.95e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDKN1A—breast cancer	5.1e-06	4.95e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTEN—breast cancer	5.09e-06	4.94e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP9—breast cancer	5.07e-06	4.92e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	5.05e-06	4.9e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTEN—breast cancer	5.04e-06	4.89e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK8—breast cancer	4.99e-06	4.84e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—breast cancer	4.98e-06	4.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK8—breast cancer	4.98e-06	4.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—breast cancer	4.96e-06	4.82e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK8—breast cancer	4.93e-06	4.78e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—breast cancer	4.91e-06	4.77e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SRC—breast cancer	4.73e-06	4.59e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SRC—breast cancer	4.72e-06	4.58e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SRC—breast cancer	4.67e-06	4.53e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VEGFA—breast cancer	4.61e-06	4.47e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VEGFA—breast cancer	4.59e-06	4.46e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STAT3—breast cancer	4.56e-06	4.43e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—breast cancer	4.56e-06	4.42e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VEGFA—breast cancer	4.55e-06	4.42e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STAT3—breast cancer	4.55e-06	4.41e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STAT3—breast cancer	4.5e-06	4.37e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK3—breast cancer	4.36e-06	4.23e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK3—breast cancer	4.35e-06	4.22e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK3—breast cancer	4.3e-06	4.18e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CA—breast cancer	4.29e-06	4.16e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MYC—breast cancer	4.24e-06	4.12e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TGFB1—breast cancer	4.23e-06	4.11e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MYC—breast cancer	4.23e-06	4.1e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TGFB1—breast cancer	4.22e-06	4.09e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MYC—breast cancer	4.19e-06	4.06e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TGFB1—breast cancer	4.18e-06	4.05e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EGFR—breast cancer	4.15e-06	4.03e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EGFR—breast cancer	4.13e-06	4.01e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EGFR—breast cancer	4.09e-06	3.97e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KRAS—breast cancer	3.92e-06	3.8e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KRAS—breast cancer	3.91e-06	3.79e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KRAS—breast cancer	3.87e-06	3.75e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	3.6e-06	3.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	3.59e-06	3.48e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	3.55e-06	3.45e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—breast cancer	3.51e-06	3.4e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TP53—breast cancer	3.48e-06	3.38e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TP53—breast cancer	3.47e-06	3.37e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TP53—breast cancer	3.44e-06	3.34e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HRAS—breast cancer	3.33e-06	3.23e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HRAS—breast cancer	3.32e-06	3.22e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HRAS—breast cancer	3.29e-06	3.19e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6—breast cancer	3.19e-06	3.09e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6—breast cancer	3.18e-06	3.08e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6—breast cancer	3.15e-06	3.05e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—breast cancer	2.94e-06	2.85e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—breast cancer	2.93e-06	2.84e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—breast cancer	2.9e-06	2.82e-05	CbGpPWpGaD
